Global Viral Gene Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 214 pages | ID: GABE547F2941EN
Bosson Research

Abstracts

Report Overview

Gene therapy is the treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to the target tissue/cells, which is carried out by gene delivery vehicles called vectors.

This report provides a deep insight into the global Viral Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Gene Therapy market in any manner.

Global Viral Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Lonza

Biogen

Catalent

Gilead Sciences

Sarepta Therapeutics

Novartis

Amgen

Ionis Pharmaceuticals

Spark Therapeutics

Shanghai Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Market Segmentation (by Type)

Integrating Viral Vectors

Non-Integrating Viral Vectors

Market Segmentation (by Application)

Metabolic Diseases

Cardiovascular Diseases

Muscular Diseases

Hematologic Diseases

Ophthalmologic Diseases

Infectious Diseases

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Viral Gene Therapy Market
• Overview of the regional outlook of the Viral Gene Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Gene Therapy
1.2 Key Market Segments
1.2.1 Viral Gene Therapy Segment by Type
1.2.2 Viral Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Viral Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Viral Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Viral Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Viral Gene Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Viral Gene Therapy Product Life Cycle
3.3 Global Viral Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Viral Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Viral Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Viral Gene Therapy Manufacturing Sites, Area Served, Product Type
3.8 Viral Gene Therapy Market Competitive Situation and Trends
3.8.1 Viral Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Viral Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Viral Gene Therapy Industry Chain Analysis
4.1 Viral Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Viral Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Viral Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Viral Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 Global Viral Gene Therapy Market by Region
6.1 Global Viral Gene Therapy Market Size by Region
6.1.1 Global Viral Gene Therapy Market Size by Region
6.1.2 Global Viral Gene Therapy Market Size Market Share by Region
6.2 Global Viral Gene Therapy Sales by Region
6.2.1 Global Viral Gene Therapy Sales by Region
6.2.2 Global Viral Gene Therapy Sales Market Share by Region
7 North America Market Overview
7.1 North America Viral Gene Therapy Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Viral Gene Therapy Market Size by Type
7.3 North America Viral Gene Therapy Market Size by Application
8 Europe Market Overview
8.1 Europe Viral Gene Therapy Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Viral Gene Therapy Market Size by Type
8.3 Europe Viral Gene Therapy Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Viral Gene Therapy Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Viral Gene Therapy Market Size by Type
9.3 Asia-Pacific Viral Gene Therapy Market Size by Application
10 South America Market Overview
10.1 South America Viral Gene Therapy Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Viral Gene Therapy Market Size by Type
10.3 South America Viral Gene Therapy Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Viral Gene Therapy Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Viral Gene Therapy Market Size by Type
11.3 Middle East and Africa Viral Gene Therapy Market Size by Application
12 Viral Gene Therapy Market Production by Region
12.1 Global Production of Viral Gene Therapy by Region(2020-2025)
12.2 Global Viral Gene Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Viral Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Viral Gene Therapy Production
12.4.1 North America Viral Gene Therapy Production Growth Rate (2020-2025)
12.4.2 North America Viral Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Viral Gene Therapy Production
12.5.1 Europe Viral Gene Therapy Production Growth Rate (2020-2025)
12.5.2 Europe Viral Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Viral Gene Therapy Production (2020-2025)
12.6.1 Japan Viral Gene Therapy Production Growth Rate (2020-2025)
12.6.2 Japan Viral Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Viral Gene Therapy Production (2020-2025)
12.7.1 China Viral Gene Therapy Production Growth Rate (2020-2025)
12.7.2 China Viral Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
13 Viral Gene Therapy Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Viral Gene Therapy Sales Market Share by Type (2020-2033)
13.3 Global Viral Gene Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Viral Gene Therapy Price by Type (2020-2033)
14 Viral Gene Therapy Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Viral Gene Therapy Market Sales by Application (2020-2033)
14.3 Global Viral Gene Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Viral Gene Therapy Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Lonza
15.1.1 Lonza Basic Information
15.1.2 Lonza Viral Gene Therapy Product Overview
15.1.3 Lonza Viral Gene Therapy Product Market Performance
15.1.4 Lonza Business Overview
15.1.5 Lonza SWOT Analysis
15.1.6 Lonza Recent Developments
15.2 Biogen
15.2.1 Biogen Basic Information
15.2.2 Biogen Viral Gene Therapy Product Overview
15.2.3 Biogen Viral Gene Therapy Product Market Performance
15.2.4 Biogen Business Overview
15.2.5 Biogen SWOT Analysis
15.2.6 Biogen Recent Developments
15.3 Catalent
15.3.1 Catalent Basic Information
15.3.2 Catalent Viral Gene Therapy Product Overview
15.3.3 Catalent Viral Gene Therapy Product Market Performance
15.3.4 Catalent Business Overview
15.3.5 Catalent SWOT Analysis
15.3.6 Catalent Recent Developments
15.4 Gilead Sciences
15.4.1 Gilead Sciences Basic Information
15.4.2 Gilead Sciences Viral Gene Therapy Product Overview
15.4.3 Gilead Sciences Viral Gene Therapy Product Market Performance
15.4.4 Gilead Sciences Business Overview
15.4.5 Gilead Sciences Recent Developments
15.5 Sarepta Therapeutics
15.5.1 Sarepta Therapeutics Basic Information
15.5.2 Sarepta Therapeutics Viral Gene Therapy Product Overview
15.5.3 Sarepta Therapeutics Viral Gene Therapy Product Market Performance
15.5.4 Sarepta Therapeutics Business Overview
15.5.5 Sarepta Therapeutics Recent Developments
15.6 Novartis
15.6.1 Novartis Basic Information
15.6.2 Novartis Viral Gene Therapy Product Overview
15.6.3 Novartis Viral Gene Therapy Product Market Performance
15.6.4 Novartis Business Overview
15.6.5 Novartis Recent Developments
15.7 Amgen
15.7.1 Amgen Basic Information
15.7.2 Amgen Viral Gene Therapy Product Overview
15.7.3 Amgen Viral Gene Therapy Product Market Performance
15.7.4 Amgen Business Overview
15.7.5 Amgen Recent Developments
15.8 Ionis Pharmaceuticals
15.8.1 Ionis Pharmaceuticals Basic Information
15.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Overview
15.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product Market Performance
15.8.4 Ionis Pharmaceuticals Business Overview
15.8.5 Ionis Pharmaceuticals Recent Developments
15.9 Spark Therapeutics
15.9.1 Spark Therapeutics Basic Information
15.9.2 Spark Therapeutics Viral Gene Therapy Product Overview
15.9.3 Spark Therapeutics Viral Gene Therapy Product Market Performance
15.9.4 Spark Therapeutics Business Overview
15.9.5 Spark Therapeutics Recent Developments
15.10 Shanghai Sunway Biotech
15.10.1 Shanghai Sunway Biotech Basic Information
15.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Overview
15.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product Market Performance
15.10.4 Shanghai Sunway Biotech Business Overview
15.10.5 Shanghai Sunway Biotech Recent Developments
15.11 SIBIONO
15.11.1 SIBIONO Basic Information
15.11.2 SIBIONO Viral Gene Therapy Product Overview
15.11.3 SIBIONO Viral Gene Therapy Product Market Performance
15.11.4 SIBIONO Business Overview
15.11.5 SIBIONO Recent Developments
15.12 AnGes
15.12.1 AnGes Basic Information
15.12.2 AnGes Viral Gene Therapy Product Overview
15.12.3 AnGes Viral Gene Therapy Product Market Performance
15.12.4 AnGes Business Overview
15.12.5 AnGes Recent Developments
15.13 Orchard Therapeutics
15.13.1 Orchard Therapeutics Basic Information
15.13.2 Orchard Therapeutics Viral Gene Therapy Product Overview
15.13.3 Orchard Therapeutics Viral Gene Therapy Product Market Performance
15.13.4 Orchard Therapeutics Business Overview
15.13.5 Orchard Therapeutics Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Viral Gene Therapy Market Size by Type (M USD)
Table 4. Global Viral Gene Therapy Market Size by Application (M USD)
Table 5. Viral Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Viral Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Viral Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Viral Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Viral Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2024)
Table 11. Global Market Viral Gene Therapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Viral Gene Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Viral Gene Therapy Product Type
Table 14. Global Viral Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Viral Gene Therapy Market Size Comparison by Region (M USD)
Table 26. Global Viral Gene Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Viral Gene Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Viral Gene Therapy Sales by Region (2020-2033) & (K MT)
Table 29. Global Viral Gene Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Viral Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Viral Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 32. North America Viral Gene Therapy Sales by Type (K MT)
Table 33. North America Viral Gene Therapy Market Size by Type (M USD)
Table 34. North America Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 35. North America Viral Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Viral Gene Therapy Sales by Application (K MT)
Table 37. North America Viral Gene Therapy Market Size by Application (M USD)
Table 38. North America Viral Gene Therapy Sales (K MT) by Application (2020-2033)
Table 39. North America Viral Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Viral Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Viral Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 42. Europe Viral Gene Therapy Sales by Type (K MT)
Table 43. Europe Viral Gene Therapy Market Size by Type (M USD)
Table 44. Europe Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 45. Europe Viral Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Viral Gene Therapy Sales by Application (K MT)
Table 47. Europe Viral Gene Therapy Market Size by Application (M USD)
Table 48. Europe Viral Gene Therapy Sales (K MT) by Application (2020-2033)
Table 49. Europe Viral Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Viral Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Viral Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Viral Gene Therapy Sales by Type (K MT)
Table 53. Asia-Pacific Viral Gene Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Viral Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Viral Gene Therapy Sales by Application (K MT)
Table 57. Asia-Pacific Viral Gene Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Viral Gene Therapy Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Viral Gene Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Viral Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Viral Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 62. South America Viral Gene Therapy Sales by Type (K MT)
Table 63. South America Viral Gene Therapy Market Size by Type (M USD)
Table 64. South America Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 65. South America Viral Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Viral Gene Therapy Sales by Application (K MT)
Table 67. South America Viral Gene Therapy Market Size by Application (M USD)
Table 68. South America Viral Gene Therapy Sales (K MT) by Application (2020-2033)
Table 69. South America Viral Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Viral Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Viral Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Viral Gene Therapy Sales by Type (K MT)
Table 73. Middle East and Africa Viral Gene Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Viral Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Viral Gene Therapy Sales by Application (K MT)
Table 77. Middle East and Africa Viral Gene Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Viral Gene Therapy Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Viral Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Viral Gene Therapy Production (K MT) by Region(2020-2025)
Table 81. Global Viral Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Viral Gene Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Viral Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Viral Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Viral Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Viral Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Viral Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Viral Gene Therapy Sales by Type (K MT)
Table 89. Global Viral Gene Therapy Market Size by Type (M USD)
Table 90. Global Viral Gene Therapy Sales (K MT) by Type (2020-2033)
Table 91. Global Viral Gene Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Viral Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Viral Gene Therapy Market Size Share by Type (2020-2033)
Table 94. Global Viral Gene Therapy Sales (K MT) by Application
Table 95. Global Viral Gene Therapy Market Size by Application(M USD)
Table 96. Global Viral Gene Therapy Sales by Application (2020-2033) & (K MT)
Table 97. Global Viral Gene Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Viral Gene Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Viral Gene Therapy Market Share by Application (2020-2033)
Table 100. Global Viral Gene Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Lonza Basic Information
Table 102. Lonza Viral Gene Therapy Product Overview
Table 103. Lonza Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Lonza Business Overview
Table 105. Lonza SWOT Analysis
Table 106. Lonza Recent Developments
Table 107. Biogen Basic Information
Table 108. Biogen Viral Gene Therapy Product Overview
Table 109. Biogen Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Biogen Business Overview
Table 111. Biogen SWOT Analysis
Table 112. Biogen Recent Developments
Table 113. Catalent Basic Information
Table 114. Catalent Viral Gene Therapy Product Overview
Table 115. Catalent Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Catalent Business Overview
Table 117. Catalent SWOT Analysis
Table 118. Catalent Recent Developments
Table 119. Gilead Sciences Basic Information
Table 120. Gilead Sciences Viral Gene Therapy Product Overview
Table 121. Gilead Sciences Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Gilead Sciences Business Overview
Table 123. Gilead Sciences Recent Developments
Table 124. Sarepta Therapeutics Basic Information
Table 125. Sarepta Therapeutics Viral Gene Therapy Product Overview
Table 126. Sarepta Therapeutics Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Sarepta Therapeutics Business Overview
Table 128. Sarepta Therapeutics Recent Developments
Table 129. Novartis Basic Information
Table 130. Novartis Viral Gene Therapy Product Overview
Table 131. Novartis Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Novartis Business Overview
Table 133. Novartis Recent Developments
Table 134. Amgen Basic Information
Table 135. Amgen Viral Gene Therapy Product Overview
Table 136. Amgen Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Amgen Business Overview
Table 138. Amgen Recent Developments
Table 139. Ionis Pharmaceuticals Basic Information
Table 140. Ionis Pharmaceuticals Viral Gene Therapy Product Overview
Table 141. Ionis Pharmaceuticals Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Ionis Pharmaceuticals Business Overview
Table 143. Ionis Pharmaceuticals Recent Developments
Table 144. Spark Therapeutics Basic Information
Table 145. Spark Therapeutics Viral Gene Therapy Product Overview
Table 146. Spark Therapeutics Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Spark Therapeutics Business Overview
Table 148. Spark Therapeutics Recent Developments
Table 149. Shanghai Sunway Biotech Basic Information
Table 150. Shanghai Sunway Biotech Viral Gene Therapy Product Overview
Table 151. Shanghai Sunway Biotech Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Shanghai Sunway Biotech Business Overview
Table 153. Shanghai Sunway Biotech Recent Developments
Table 154. SIBIONO Basic Information
Table 155. SIBIONO Viral Gene Therapy Product Overview
Table 156. SIBIONO Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. SIBIONO Business Overview
Table 158. SIBIONO Recent Developments
Table 159. AnGes Basic Information
Table 160. AnGes Viral Gene Therapy Product Overview
Table 161. AnGes Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. AnGes Business Overview
Table 163. AnGes Recent Developments
Table 164. Orchard Therapeutics Basic Information
Table 165. Orchard Therapeutics Viral Gene Therapy Product Overview
Table 166. Orchard Therapeutics Viral Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Orchard Therapeutics Business Overview
Table 168. Orchard Therapeutics Recent Developments
List of Figures
Figure 1. Product Picture of Viral Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Viral Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Viral Gene Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Viral Gene Therapy Product Life Cycle
Figure 13. Viral Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Viral Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Viral Gene Therapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Viral Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Viral Gene Therapy
Figure 19. Global Viral Gene Therapy Market PEST Analysis
Figure 20. Global Viral Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Viral Gene Therapy Market Size by Region
Figure 27. Global Viral Gene Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Viral Gene Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Viral Gene Therapy Market Size (M USD) by Country
Figure 33. USA Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Viral Gene Therapy Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Viral Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Viral Gene Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Viral Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Viral Gene Therapy Market Size (M USD)by Type
Figure 40. North America Viral Gene Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Viral Gene Therapy Market Size (M USD) by Country
Figure 45. Germany Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Viral Gene Therapy Market Size (M USD) by Type
Figure 56. Europe Viral Gene Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Viral Gene Therapy Market Size (M USD) by Country
Figure 61. China Viral Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Viral Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Viral Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Viral Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Viral Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Viral Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Viral Gene Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Viral Gene Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Viral Gene Therapy Market Size (M USD) by Country
Figure 77. Brazil Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Viral Gene Therapy Market Size (M USD) by Type
Figure 84. South America Viral Gene Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Viral Gene Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Viral Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Viral Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Viral Gene Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Viral Gene Therapy Market Size (M USD) by Application
Figure 101. Global Viral Gene Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Viral Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Viral Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Viral Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. China Viral Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Viral Gene Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Viral Gene Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Viral Gene Therapy by Type in 2024
Figure 110. Market Size Share of Viral Gene Therapy by Type (2020-2033)
Figure 111. Market Size Share of Viral Gene Therapy by Type in 2024
Figure 112. Global Viral Gene Therapy Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Viral Gene Therapy Market Size by Application(M USD)
Figure 115. Global Viral Gene Therapy Market Share by Application
Figure 116. Global Viral Gene Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Viral Gene Therapy Sales Market Share by Application in 2024
Figure 118. Global Viral Gene Therapy Market Share by Application (2020-2033)
Figure 119. Global Viral Gene Therapy Market Share by Application in 2024
Figure 120. Global Viral Gene Therapy Sales Growth Rate by Application (2020-2033)